Serko Limited — Director's Dealing 2020

Feb 4, 2020

==> picture [116 x 31] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and		Serko Limited 10-Jan-20 Claudia Batten Serko Limited Not applicable Director Ordinary shares Registered holder and beneficial owner 181,818 ordinary shares 81,818 ordinary shares Claudia Batten Unknown 1 31-Jan-20 On market sale of ordinary shares held pursuant to the Serko Director Share Loan Facility (to in large part repay the loan facility and fund tax obligations associated with repayment of the loan facility). Unknown $523,755.50 ($5.238/share) 100,000 No Not applicable Not applicable Ordinary shares Beneficial owner 30,097.09 ordinary shares held under the Serko NED Fixed Trading Plan Custodian Services Limited as custodian for Claudia Batten Not applicable 05-Feb-20
Name of listed issuer:
Date this disclosure made:
Date of last disclosure:
Director or senior manager giving disclosure
Full name(s):
Name of listed issuer:
Name of related body corporate (if applicable):
Position held in listed issuer:
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affected quoted financial products:		Ordinary shares
Nature of the affected relevant interest(s):		Registered holder and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:		181,818 ordinary shares
Number held in class after acquisition or disposal:		81,818 ordinary shares
Current registered holder(s):		Claudia Batten
Registered holder(s) once transfers are registered:		Unknown
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during th closed period:		Not applicable
Date of the prior written clearance (if any):		Not applicable
Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative:
Type of derivative:		Not applicable

Details of derivative,-

Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		Not applicable
A statement as to whether the derivative is cash settled or physically settled:		Not applicable
Maturity date of the derivative (if any):		Not applicable
Expiry date of the derivative (if any):		Not applicable
The price's specified terms (if any):		Not applicable
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:		Not applicable
For that derivative relevant interest,-
Parties to the derivative:		Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in t derivative:		Not applicable
Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:		04-Feb-20